AMENDED AND RESTATED SHARE TRANSFER AGREEMENTShare Transfer Agreement • June 16th, 2021 • Cellect Biotechnology Ltd. • Surgical & medical instruments & apparatus • Delaware
THIS AMENDED AND RESTATED SHARE TRANSFER AGREEMENT (this “Agreement”) is made and entered into as of May 27, 2021 (the “Effective Date”), by and between EnCellX, Inc., a Delaware corporation (the “Purchaser”) and Cellect Biotechnology Ltd., an Israeli company (the “Seller”). The Purchaser and the Seller shall each be referred to in this Agreement as a “Party” and together as the “Parties”.
